Fulcrum Therapeutics, Inc. — All Filings
468 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POS EX
POSASR
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SEC STAFF LETTER | — | 9999999997-19-005683 | Jun 20, 2019 | — |
| UPLOAD | — | 0000000000-19-009993 | Jun 19, 2019 | — |
| DRS/A | — | 0000912057-19-000241 | Jun 6, 2019 | — |
| DRSLTR | — | 0001410578-19-000287 | Jun 5, 2019 | — |
| UPLOAD | — | 0000000000-19-009042 | May 29, 2019 | — |
| SEC STAFF LETTER | — | 9999999997-19-004388 | May 13, 2019 | — |
| DRS | — | 0000912057-19-000198 | May 1, 2019 | — |
| D | — | 0001680581-18-000002 | Sep 5, 2018 | — |
| D/A | — | 0001680581-17-000002 | Jul 25, 2017 | — |
| D | — | 0001680581-17-000001 | May 10, 2017 | — |
| D | — | 0001680581-16-000001 | Jul 25, 2016 | — |